Ruojin Yao

Ruojin Yao


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JLJing Long
Jing Long
YHYan Huang
Yan Huang
ZTZhengshan Tang
Zhengshan Tang
YSYali Shan
Yali Shan
DFDou Feng
Dou Feng
XNXin Ni
Xin Ni
We have previously demonstrated that placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) dysfunction contributes to PE pathogenesis. We sought to elucidate molecular mechanisms underlying 11β-HSD2 dysfunction-induced PE and to seek potential therapeutic targets using a 11β-HSD2 dysfunction-induced PE-like rat model as well as cultured extravillous trophoblasts (EVTs) since PE begins with impaired function of EVTs. In 11β-HSD2 dysfunction-induced PE-like rat model, we revealed that placental mitochondrial dysfunction occurred, which was associated with mitDNA instability and impaired mitochondrial dynamics, such as decreased optic atrophy 1 (OPA1) expression. MitoTEMPO treatment significantly alleviated the hallmark of PE-like features and improved mitDNA stability and mitochondrial dynamics in the placentas of rat PE-like model. In cultured human EVTs, we found that 11β-HSD2 dysfunction led to mitochondrial dysfunction and disrupted mtDNA stability. MitoTEMPO treatment improved impaired invasion and migration induced by 11β-HSD2 dysfunction in cultured EVTs. Further, we revealed that OPA1 was one of the key factors that mediated 11β-HSD2 dysfunction-induced excess ROS production, mitochondrial dysfunction and mtDNA reduction. Our data indicates that 11β-HSD2 dysfunction causes mitochondrial dysfunctions, which impairs trophoblast function and subsequently results in PE development. Our study immediately highlights that excess ROS is a potential therapeutic target for PE.

3 March 2020 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
PDF file
DGDewei Guo
Dewei Guo
YSYuting Shi
Yuting Shi
WJWenyan Jian
Wenyan Jian
YFYimei Fu
Yimei Fu
HYHui Yang
Hui Yang
RYRuojin Yao
Ruojin Yao

8 March 2025 in Biomedicines
Verified
Journal Article
Open access
YFYing Fu
Ying Fu
QLQiaoshu Liu
Qiaoshu Liu
RYRuojin Yao
Ruojin Yao
YFYimei Fu
Yimei Fu
LDLei Dai
Lei Dai
JLJingzhi Li
Jingzhi Li
Background: Antenatal hydronephrosis (ANH) is the most common congenital renal and urinary tract anomaly, and parenchymal damage and renal fibrosis due to pathological hydronephrosis are the main causes of end-stage renal disease in children and chronic kidney disease in adults. At present, there is no validated biomarker for ANH, and diagnostic criteria other than prenatal ultrasonography (US) assessment are lacking. Therefore, we assessed to determine if biomarkers extracted from amniotic fluid small extracellular vesicles (sEVs) might be used as ANH diagnosis. Methods: With congenital ureteropelvic junction obstruction (UPJO) as the ultimate diagnosis, 10 pregnant women with Grade III-IV ANH and 10 normal pregnant women were recruited. The sEVs were extracted from amniotic fluid supernatant of all samples. Transcriptomic sequencing of sEVs in the discovery cohort identified the differential expression profiles for ANH. The known differentially expressed lncRNAs (DE-lncRNAs) were assessed by qRT–PCR in the validation cohort. Results: We explored the global RNA expression in sEVs from amniotic fluid. The differential expression profiles of both mRNAs and lncRNAs were related to fetal kidney development. Six known DE-lncRNAs were identified for ANH, and three of those with high expression were verified in more ANH samples. In particular, the upregulated LINC02863 and its target genes were associated with renal development and morphogenesis. The four predicted novel lncRNAs in high expression were also related to mesenchymal morphogenesis and the STAT3 signaling pathway and may play roles in ANH. Conclusions: We identified differentially expressed RNAs of all species in the sEVs from amniotic fluid, and the validated known DE-lncRNAs might serve as promising diagnostic biomarkers for ANH.

25 September 2023 in Prenatal Diagnosis
Verified
Journal Article
Closed access
HTHang‐Jing Tan
Hang‐Jing Tan
WJWen‐Yan Jian
Wen‐Yan Jian
CLChao Lv
Chao Lv
DGDe‐Wei Guo
De‐Wei Guo
ZLZheng‐Chang Liao
Zheng‐Chang Liao
HXHong-Mei Xiao
Hong-Mei Xiao

28 November 2020
Verified
Journal Article
Closed access
WJWenyan Jian
Wenyan Jian
RYRuojin Yao
Ruojin Yao